Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
57.7% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
26
users have liked this narrative
7
users have commented on this narrative
76
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
28.0% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
35
users have liked this narrative
6
users have commented on this narrative
96
users have followed this narrative
Updated
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
20.6% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
JCDecaux
AN
AnalystLowTarget
Consensus Narrative from 13 Analysts
French Policies And Rivals Will Dampen Expansion But Brighten Prospects
Key Takeaways Heavy reliance on digital transformation faces regulatory and political roadblocks in key markets, risking slower top-line expansion and delayed margin improvement. Diversified global footprint enhances stability, but rising competition for public tenders and shifts in urban mobility could pressure future earnings and occupancy rates.
View narrative
€16.00
FV
7.1% undervalued
intrinsic discount
3.20%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Tata Chemicals
AN
AnalystLowTarget
Consensus Narrative from 8 Analysts
Soda Ash Excess Capacity And Rising Costs Will Squeeze Margins
Key Takeaways Global overcapacity, weak demand, and regulatory headwinds are likely to suppress earnings and pressure margins for an extended period. High capital outlay and slow progress in specialty segments limit free cash flow and threaten future earnings growth.
View narrative
₹780.00
FV
22.0% overvalued
intrinsic discount
5.26%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Johnson Matthey
AN
AnalystLowTarget
Consensus Narrative from 10 Analysts
Automotive Electrification Will Shrink Clean Air Business Margins
Key Takeaways Retreat from battery materials and key divestitures narrows growth opportunities, increasing reliance on declining markets vulnerable to structural changes. Heightened competition, regulatory pressure, and volatile precious metals pricing threaten margins, earnings stability, and long-term cash flow consistency.
View narrative
UK£13.95
FV
27.3% overvalued
intrinsic discount
-45.89%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
1 day ago
author updated this narrative
Aroundtown
AN
AnalystLowTarget
Consensus Narrative from 15 Analysts
Weakening Office Demand Will Shrink Margins Despite Green Transitions
Key Takeaways Weakened office demand, demographic shifts, and stricter environmental rules threaten revenue growth, property values, and increase pressure on profit margins. Substantial capital needs for compliance, refinancing risk, and required modernization investments are likely to erode cash flow and returns to shareholders.
View narrative
€2.00
FV
66.1% overvalued
intrinsic discount
-0.31%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Unicaja Banco
AN
AnalystLowTarget
Consensus Narrative from 17 Analysts
Digital Banking Shifts And Spain Demographics Will Erode Profit Margins
Key Takeaways Digital disruption and aggressive competition threaten Unicaja's revenues and margins, exposing weaknesses in technological innovation and customer retention. Structural and demographic challenges in core regions constrain loan demand and deposit growth, hampering long-term profitability and earnings expansion.
View narrative
€1.60
FV
48.6% overvalued
intrinsic discount
-2.94%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Poonawalla Fincorp
AN
AnalystLowTarget
Consensus Narrative from 6 Analysts
NBFC Market Share Will Decline Amid Regulatory And Digital Pressures
Key Takeaways Rising fintech competition, regulatory tightening, and sector-wide commoditization threaten market share, margins, and overall profitability. Aggressive unsecured lending and reliance on external borrowing heighten credit, funding, and economic downturn risks.
View narrative
₹310.00
FV
42.7% overvalued
intrinsic discount
85.24%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Voestalpine
AN
AnalystLowTarget
Consensus Narrative from 12 Analysts
Rising Carbon Costs And Market Overcapacity Will Crush Margins
Key Takeaways Incomplete green steel investments and regulatory pressures threaten future profitability and margins amidst rising carbon costs and stricter emissions rules. Reliance on legacy steel production, shrinking European demand, and global oversupply risk persistent margin and revenue decline unless Voestalpine innovates rapidly.
View narrative
€21.50
FV
24.7% overvalued
intrinsic discount
0.28%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Mangalore Refinery and Petrochemicals
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Renewable Shift And Overcapacity Will Erode Refining Profitability
Key Takeaways Global decarbonization trends and the rise of electric vehicles threaten demand for MRPL's core petroleum products, pressuring revenue and growth prospects. Environmental regulations and industry overcapacity are expected to squeeze margins, while operational concentration increases vulnerability to disruptions and volatile earnings.
View narrative
₹100.00
FV
25.7% overvalued
intrinsic discount
-4.03%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
1 day ago
author updated this narrative
Laurus Labs
AN
AnalystLowTarget
Consensus Narrative from 13 Analysts
Global Healthcare Regulation Will Squeeze Margins Amid Rising Costs
Key Takeaways Regulatory changes and sustainable manufacturing trends are set to elevate costs and compress margins, challenging Laurus Labs' long-term profitability. Shifts in industry focus and pricing pressures, combined with underperforming new divisions and intense competition, threaten growth and core business relevance.
View narrative
₹303.09
FV
174.3% overvalued
intrinsic discount
11.67%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Value any company in seconds
Popular companies